REVO Oncology Diagnostics Inc.
CIK 2114097 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for REVO Oncology Diagnostics Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Apr 13, 2026 | D | 0002114097-26-000001 |